Altered Central and Peripheral Inflammation in Depression

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cells of the Nervous System".

Deadline for manuscript submissions: 30 September 2024 | Viewed by 221

Special Issue Editors

E-Mail Website
Guest Editor
Vinča Institute of Nuclear Science, University of Belgrade, Belgrade, Serbia
Interests: depression; mental health; neuropsychopharmacology; brain disorders; preclinical studies

E-Mail Website
Guest Editor
Vinča Institute of Nuclear Science, University of Belgrade, Belgrade, Serbia
Interests: pesticides; organophosphates; depression; acetylcholinesterase
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Depression is a complex and heterogenic psychiatric disease that affects more than 300 million of people worldwide and represents the number one cause of human disability. Accumulating preclinical evidence suggests that inflammatory processes in the brain and periphery are tightly associated with the etiopathology of depression. Additionally, a number of clinical data report high comorbidity between depression and inflammation-related medical conditions on the periphery of the body that are characterized by disrupted innate and immune responses and aberrant production of pro-inflammatory cytokines, and increased neurotoxicity. Furthermore, inflammation is also reported as one of the key factors in the pathophysiology of several neurological brain disorders that exhibit high comorbidity with depression. In this Special Issue, we will give an overview of how peripheral inflammation derived from different challenges health states communicates with the brain and affects its function and structure on a molecular level, and promotes susceptibility to depression. Additionally, we will cover some aspects of the bidirectional therapeutic approach, from the brain to the periphery and vice versa, and whether if we control the brain or peripheral inflammation, we can normalize depressive symptomatology and peripheral abnormalities.

We look forward to receiving your contributions.

Dr. Miloš Mitić
Dr. Tamara Lazarević-Pašti
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • depression
  • inflammation
  • comorbidity
  • disease
  • therapy
  • immunopsychiatry

Published Papers

This special issue is now open for submission.
Back to TopTop